Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Dermatomyositis and Polymyositis
NCT03092154Terminated
- Sponsor
- Universidade de São Paulo
- Start
- Jan 2017
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of atorvastatin in dyslipidemia (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Endothelial function at 12 weeks. Started Jan 2017; status: terminated.
02
Drugs
atorvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT03092154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03092154.